Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
Transgender people
What the Trans Community Needs to Know About New Expert Recommendations

New provider recommendations aimed at doctors caring for trans patients were published on July 1 in the Annals of Internal Medicine, including changes that overall make it easier to identify trans patients and provide medical care for trans individuals.

Published
08 July 2019
From
The Body
Achieving the 90-90-90 target
WHO’s “Treat All” Policy Had Immediate Effect on Global HIV Treatment Rates

The World Health Organization (WHO) recommendation in 2015 that all nations provide HIV treatment regardless of an individual’s CD4 count had a rapid and stark effect on increasing rates of rapid access to antiretrovirals (ARVs) in various developing nations.

Published
04 July 2019
From
POZ
Cardiovascular disease
American Heart Association Scientific Statement on CVD and HIV

A new scientific statement from the American Heart Association (AHA) provides "pragmatic" recommendations on how to approach cardiovascular disease (CVD) prevention and management in the growing number of people living with HIV infection.

Published
04 June 2019
From
Medscape (requires free registration)
Cardiovascular disease
As HIV patients live longer, heart disease might be their next challenge

As people with HIV live longer, they also find themselves at higher risk for heart attack, stroke and other types of cardiovascular disease. A new American Heart Association report hopes to raise awareness about that connection, along with pointing out cardiovascular disease prevention and treatment strategies for an emerging population with unique concerns researchers have only begun to explore.

Published
04 June 2019
From
American Heart Association
Pharmaceutical industry
Medicare decides against tighter management of HIV drugs

The Department of Health and Human Services will continue barring Medicare Part D plans from applying the drug utilization management tools prior authorization and step therapy for beneficiaries taking HIV antiretroviral drugs. A rule proposed in November 2018 would have permitted such practices. Gilead voiced opposition to the original proposal, saying physicians need to have the flexibility to prescribe the right medicines for patients.

Published
21 May 2019
From
BioPharma Dive
HIV treatment for children and young people
U.S. Revises Pediatric HIV Treatment Guidelines

Changes include new information about risks associated with Tivicay during pregnancy and a removal of older drugs owing to toxicities.

Published
23 April 2019
From
Poz
Treatment guidelines
Avoiding Dolutegravir in Young Women With HIV: Time for a Rethink?

Total deaths for women with HIV and their children are projected to be lower with dolutegravir-based (Tivicay) antiretroviral therapy (ART) versus efavirenz-based (Sustiva) ART, a model-based analysis found.

Published
05 April 2019
From
MedPage Today
Testing and health monitoring
For Our Stable HIV Patients, Why Are We Still Sending All These Lab Tests So Often?

Do the guidelines for laboratory monitoring still make sense when our HIV treatments have become so safe and effective?

Published
29 January 2019
From
NEJM Journal Watch
HIV treatment
Dolutegravir- why new does not automatically mean better

As has been previously reported by Spotlight, a new and exciting anti-retroviral, dolutegravir, is soon to become widely available in South Africa. Whilst its very real advantages have been extensively reported, the potential disadvantages have received relatively little attention.

Published
25 January 2019
From
Spotlight
Treatment guidelines
HIV care is threatened by proposed changes to Medicare Part D

Optimal HIV care includes early and uninterrupted access to effective antiretroviral medications. Proposed changes to Medicare Part D threatens that.

Published
25 January 2019
From
STAT
← First12345...25Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.